Phospholipid metabolites in recurrent glioblastoma: in vivo markers detect different tumor phenotypes before and under antiangiogenic therapy.

por Elke Hattingen, Oliver Bähr, Johannes Rieger, Stella Blasel, Joachim Steinbach, Ulrich Pilatus
Publicado 2013

Multidrug-resistant organisms (MDROs) in patients with subarachnoid hemorrhage (SAH)

por Ha-Young Rhim, Sae-Yeon Won, Sepide Kashefiolasl, Nina Brawanski, Elke Hattingen, Joachim Berkefeld, Volker Seifert, Juergen Konczalla
Publicado 2021

Functional redundancy of the premotor network in hemispherotomy patients

por Conrad C. Prillwitz, Bastian David, Gottfried Schlaug, Thomas Deller, Johannes Schramm, Robert Lindenberg, Elke Hattingen, Bernd Weber, Rainer Surges, Christian E. Elger, Theodor Rüber
Publicado 2021

The bioenergetic status relates to dopamine neuron loss in familial PD with PINK1 mutations.

por Rüediger Hilker, Ulrich Pilatus, Carsten Eggers, Johann Hagenah, Julia Roggendorf, Simon Baudrexel, Johannes C Klein, Bernd Neumaier, Gereon R Fink, Helmuth Steinmetz, Christine Klein, Elke Hattingen
Publicado 2012

Netrin-1 expression is an independent prognostic factor for poor patient survival in brain metastases.

por Patrick N Harter, Jenny Zinke, Alexander Scholz, Julia Tichy, Cornelia Zachskorn, Hans M Kvasnicka, Benjamin Goeppert, Céline Delloye-Bourgeois, Elke Hattingen, Christian Senft, Joachim P Steinbach, Karl H Plate, Patrick Mehlen, Dorothea Schulte, Michel Mittelbronn
Publicado 2014